Related Experiment Videos

Myxoma virus immunomodulatory protein M156R is a structural mimic of eukaryotic translation initiation factor

Theresa A Ramelot1, John R Cort, Adelinda A Yee

  • 1Environmental Molecular Sciences Laboratory, Pacific Northwest National Laboratory, Richland, WA 99352, USA.

Insights

Myxoma virus protein M156R mimics eukaryotic translation initiation factor 2 alpha subunit (eIF2alpha) by adopting a similar structure. This allows M156R to compete with eIF2alpha for binding to protein kinase PKR, inhibiting protein synthesis regulation.

Area of Science:

  • Biochemistry
  • Structural Biology
  • Virology

Background:

  • Phosphorylation of eukaryotic translation initiation factor 2 alpha subunit (eIF2alpha) at Ser51 regulates protein synthesis.
  • Viral proteins can interfere with eIF2alpha phosphorylation by binding to protein kinase PKR (PKR).

Purpose of the Study:

  • To investigate the mechanism by which myxoma virus protein M156R interacts with PKR.
  • To elucidate the structural basis for M156R's inhibition of eIF2alpha phosphorylation.

Main Methods:

  • Nuclear magnetic resonance (NMR) structure determination of M156R.
  • Homology modeling of vaccinia virus K3L.
  • Structural comparison of M156R, K3L, and human eIF2alpha.

Main Results:

  • M156R is phosphorylated by PKR and competes with eIF2alpha.
  • The NMR structure of M156R reveals a beta-barrel fold similar to eIF2alpha.
  • Structural comparison identified conserved residues and a putative PKR recognition motif.

Conclusions:

  • Myxoma virus M156R mimics eIF2alpha structure to inhibit PKR.
  • The study provides structural insights into viral mimicry of host factors.
  • Identified key residues for PKR recognition and inhibition of protein synthesis.

Related Concept Videos